Concepedia

Author

Jeanette Raleigh

Peter MacCallum Cancer Centre

Also Known As

J. M. Raleigh, J. Raleigh, J.M. Raleigh, JEANETTE M. RALEIGH, Jeanette M. Raleigh, Jeanette Raleigh, Raleigh, Jeanette

45

Publications

1.1K

Citations

14

H-Index

54

Concepts

All Affiliations

Peter MacCallum Cancer CentreThe University of MelbourneThe University of SydneyWalter and Eliza Hall Institute of Medical ResearchMelanoma Institute Australia
JR

About

Jeanette Raleigh is an author at Peter MacCallum Cancer Centre specializing in medicine, oncology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

460

2

Health Sciences

3

3

112

3

Engineering

1

1

13

4

Natural Sciences

1

1

30

5

Biochemistry

1

1

36

Jeanette Raleigh

×

16

Publications

1K

Citations

14

H-Index

YearCitations

Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA

Lavinia Tan, Shahneen Sandhu, Rebecca Lee,

Annals of Oncology

2019

177

The G2 DNA damage checkpoint targets both Wee1 and Cdc25

Jeanette Raleigh, Matthew J. O’Connell

Journal of Cell Science

2000

164

Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma

Heloise M. Halse, Andrew J. Colebatch, Pasquale Petrone,

Scientific Reports

2018

124

Circulating Tumor DNA Analysis and Functional Imaging Provide Complementary Approaches for Comprehensive Disease Monitoring in Metastatic Melanoma

Stephen Q. Wong, Jeanette Raleigh, Jason Callahan,

JCO Precision Oncology

2017

109

Activity of trametinib in K601E and L597Q BRAF mutation-positive metastatic melanoma

Samantha Bowyer, Aparna D. Rao, Megan Lyle,

Melanoma Research

2014

77

Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling

Ismael A. Vergara, Christopher Mintoff, Shahneen Sandhu,

Nature Communications

2021

73

Sustained clinical responses to tyrosine kinase inhibitor sunitinib in thyroid carcinoma

Sarah‐Jane Dawson, Nelly Conus, Guy C. Toner,

Anti-Cancer Drugs

2008

51

γδ T Cells in Merkel Cell Carcinomas Have a Proinflammatory Profile Prognostic of Patient Survival

Nicholas A. Gherardin, Kelly Waldeck, Alex Caneborg,

Cancer Immunology Research

2021

47

The survivorship experience for patients with metastatic melanoma on immune checkpoint and BRAF-MEK inhibitors

Julia Lai‐Kwon, Chloe Khoo, Serigne Lo,

Journal of Cancer Survivorship

2019

45

Detection of cell-free microbial DNA using a contaminant-controlled analysis framework

Enrique Zozaya‐Valdés, Stephen Q. Wong, Jeanette Raleigh,

Genome biology

2021

38

Page 1